-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
High Times And Lucy Scientific Discovery Launching Amanita Muscaria Mushrooms Product
High Times And Lucy Scientific Discovery Launching Amanita Muscaria Mushrooms Product
Psychedelics producer Lucy Scientific Discovery Inc. (NASDAQ:LSDI) is launching a new brand of products containing unscheduled psychoactive compounds, soon available for sale in the U.S. and all other parts of the world where legal.
The first of the brand's product lines, "Mindful by Lucy," involves Amanita Muscaria mushrooms within a proprietary blend of other natural functional ingredients and is being launched together with partner cannabis brand High Times, following a strategic investment agreement in which Lucy received $2.5 million in advertising credits.
See also: Psychedelics Producer Lucy Scientific Discovery Partners With Pramantha Group For Funding: What's Next?
Lucy will work with parent company Hightimes Holding Corp. towards distributing and marketing the products first through High Times' websites and social channels, with product launch targeted for Q2 2023.
Lucy's CEO Chris McElvany believes that adaptogens such as Amanita Muscaria mushrooms "are emerging as a leading therapeutic remedy" in the face of increasing awareness of mental health disorders. He expects the new partnership will promote the product's potential health benefits to a broader audience.
Benzinga Psychedelics Capital Conference
The second edition of the Benzinga Psychedelics Capital Conference is up next! Taking place at the Fontainebleau Miami Beach Hotel in Florida on April 13, 2023, the event's THE place to get DEALS DONE, raise money, jumpstart M&A and meet investors and key partners.
Get your tickets before prices go up.
Photo by Xan Griffin on Unsplash
Psychedelics producer Lucy Scientific Discovery Inc. (NASDAQ:LSDI) is launching a new brand of products containing unscheduled psychoactive compounds, soon available for sale in the U.S. and all other parts of the world where legal.
迷幻药制作人 露西科学探索公司(纳斯达克股票代码:LSDI) 正在推出一个含有未列入清单的精神活性化合物的新产品品牌,该产品即将在美国和世界上所有其他合法地区上市。
The first of the brand's product lines, "Mindful by Lucy," involves Amanita Muscaria mushrooms within a proprietary blend of other natural functional ingredients and is being launched together with partner cannabis brand High Times, following a strategic investment agreement in which Lucy received $2.5 million in advertising credits.
该品牌的第一条产品线 “Mindful by Lucy” 将Amanita Muscaria蘑菇与其他天然功能成分的专有混合物混合,此前Lucy签订了战略投资协议,Lucy获得了250万美元的广告信贷,随后与合作伙伴大麻品牌High Times共同推出。
See also: Psychedelics Producer Lucy Scientific Discovery Partners With Pramantha Group For Funding: What's Next?
另见:迷幻药制片人露西·科学发现与普拉曼莎集团合作筹集资金:下一步是什么?
Lucy will work with parent company Hightimes Holding Corp. towards distributing and marketing the products first through High Times' websites and social channels, with product launch targeted for Q2 2023.
露西将与母公司Hightimes Holding Corp. 合作,首先通过High Times的网站和社交渠道分销和营销这些产品,产品定于2023年第二季度发布。
Lucy's CEO Chris McElvany believes that adaptogens such as Amanita Muscaria mushrooms "are emerging as a leading therapeutic remedy" in the face of increasing awareness of mental health disorders. He expects the new partnership will promote the product's potential health benefits to a broader audience.
露西的首席执行官克里斯·麦克尔瓦尼认为,面对人们对心理健康障碍的认识不断提高,诸如Amanita Muscaria蘑菇之类的适应原 “正在成为一种主要的治疗药物”。他预计,新的合作伙伴关系将向更广泛的受众推广该产品的潜在健康益处。
Benzinga Psychedelics Capital Conference
Benzinga Psychedilis 资本会议
The second edition of the Benzinga Psychedelics Capital Conference is up next! Taking place at the Fontainebleau Miami Beach Hotel in Florida on April 13, 2023, the event's THE place to get DEALS DONE, raise money, jumpstart M&A and meet investors and key partners.
这个 第二版 Benzinga Psychedics 资本会议 接下来是!该活动于 2023 年 4 月 13 日在佛罗里达州的迈阿密海滩枫丹白露酒店举行,是完成交易、筹集资金、启动并购以及会见投资者和主要合作伙伴的地方。
Get your tickets before prices go up.
买票 在价格上涨之前。
Photo by Xan Griffin on Unsplash
照片:Xan Griffin 在 Unsplash
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧